Global CAR T Cell Therapy Market Report By Targeted Antigen (CD 19, CD 20, GD2, CD22, CD30, CD33, HER1, HER2, Meso, Egfrvlll And Others), By Therapeutic Application (Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Non Hodgkin Leukemia, Multiple Myeloma, Pancreatic Cancer, Neuroblasta, Breast Cancer, Acute Myeloid Leukemia, Hepatocellular, Carcinoma, Colorectal Cancer And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2017-2024
ID:VMR11210077
August 2018
Report Formats:

As per this study the Global CAR T Cell Therapy Market was valued USD 150 MN (by revenue) in 2017 and is anticipated to reach USD 1,581.2 MN by 2024 with a CAGR of 40%.
 
CAR T-cell therapy refers to the type of cancer treatment by injecting T-cells engineered with Chimeric Antigen Receptor (CAR) protein.  It includes infusion of engineered T cells to attack the tumor or carcinogenic cells. Basically, in this therapy, T-cells are collected, re-engineered in the laboratory with CAR protein and reinfused in the patient’s body. These T cells now act as an attacker on the tumor-causing cells. CAR T cell therapy is used in curing patients with breast cancer, pancreas cancer, colorectal cancer and various types of blood cancer.

Objectives of the Study:

  • Define and measure the global CAR T cell therapy market
  • Revenue forecast of the global CAR T cell therapy market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

 Market Dynamics
 
Rising prevalence of cancer coupled with high demand for effective treatment to cure cancer is driving the market growth. Technological advancement for advanced and reliable treatment for cancer is fueling the market growth. Growing number of patients immune to chemotherapy and radiations is opening new avenues for growth of CAR T cell therapy market. Governmental initiatives on treatment and research on combating cancer are boosting market growth. On the flip side, side effects leading to neurological problems coupled with high treatment cost are likely to restrain the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of CAR T cell therapy.
 
Market Segmentation
 
The broad CAR T cell therapy market has been sub-grouped into target antigen and therapeutic application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Target Antigen
  • CD 19
  • CD 20
  • GD2
  • CD22
  • CD30
  • CD33
  • HER1
  • HER2
  • Meso
  • Egfrvlll
  • Others
 
By Therapeutic Application
  • Acute Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia
  • Non Hodgkin Leukemia
  • Multiple Myeloma
  • Pancreatic Cancer
  • Neuroblasta
  • Breast Cancer
  • Acute Myeloid Leukemia
  • Hepatocellular
  • Carcinoma
  • Colorectal Cancer
  • Others
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for CAR T cell therapy in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe CAR T Cell Therapy Market By Revenue (USD MN)
 
Europe CAR T Cell Therapy Market By Revenue
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the CAR T cell therapy market include Bellicum Pharmaceuticals, Inc., Celgene Corporation, Cellectis, Juno Therapeutics, Kite Pharma Inc., Novartis International AG and Sorrento Therapeutics, Inc. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand. 

1. INTRODUCTION

  • Introduction To CAR T Cell Therapy
  • Report Description
    • Objectives Of The Study
    • Assumptions
  • Research Scope
  • Research Methodology
    • Data Source
 
2. EXECUTIVE SUMMARY
  • Market Highlight
  • Global CAR T Cell Therapy Market: Snapshot
 
3. MARKET ANALYSIS
  • Drivers
  • Restraints
  • Opportunities
  • Porter’s Five Forces Analysis
  • Value Chain Analysis
 
4. CAR T CELL THERAPY MARKET ANALYSIS BY TARGER ANTIGEN
  • Market In CD 19
  • Market In CD 20
  • Market In GD2
  • Market In CD22
  • Market In CD30
  • Market In CD33
  • Market In HER1
  • Market In HER2
  • Market In Meso
  • Market In Egfrvlll
  • Market In Others
 
5. CAR T CELL THERAPY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  • Market In Acute Lymphocytic Leukemia
  • Market In Chronic Lymphocytic Leukemia
  • Market In Non Hodgkin Leukemia
  • Market In Multiple Myeloma
  • Market In Pancreatic Cancer
  • Market In Neuroblasta
  • Market In Breast Cancer
  • Market In Acute Myeloid Leukemia
  • Market In Hepatocellular
  • Market In Carcinoma
  • Market In Colorectal Cancer
  • Market In Others
 
6. CAR T CELL THERAPY MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.) Market Estimates By Segments
    • Rest Of North America Market Estimates By Segments
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK) Market Estimates By Segments
    • Germany Market Estimates By Segments
    • France Market Estimates By Segments
    • Rest Of Europe Market Estimates By Segments
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China Market Estimates By Segments
    • Japan Market Estimates By Segments
    • India Market Estimates By Segments
    • Rest Of Asia Pacific Market Estimates By Segments  
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil Market Estimates By Segments
    • Rest Of Latin America Market Estimates By Segments
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East Market Estimates By Segments
    • Africa Market Estimates By Segments
 
7. COMPETITIVE LANDSCAPE OF THE CAR T CELL THERAPY COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
8. COMPANY PROFILES OF THE CAR T CELL THERAPY INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
  • Bellicum Pharmaceuticals, Inc.
  • Celgene Corporation
  • Cellectis
  • Juno Therapeutics
  • Kite Pharma Inc.
  • Novartis International AG
  • Sorrento Therapeutics, Inc.
 
* Tentative TOC
 

LIST OF TABLES
 
Table 1.  Market Highlights Of CAR T Cell Therapy
Table 2.  Global CAR T Cell Therapy Market By Target Antigen
Table 3.  Global CAR T Cell Therapy Market By Therapeutic Application
Table 4.  Global CAR T Cell Therapy Market By Geography
Table 5.  North America CAR T Cell Therapy Market
Table 6.  Europe CAR T Cell Therapy Market
Table 7.  Asia Pacific CAR T Cell Therapy Market
Table 8.  Latin America CAR T Cell Therapy Market
Table 9.  Middle East And Africa CAR T Cell Therapy Market 
Table 10. Partnership/Collaboration/Agreements
Table 11. Mergers And Acquisitions
Table 12. New Product Development
Table 13. Other Developments
  
LIST OF FIGURES
 
Fig. 1.     Market Segmentation Of CAR T Cell Therapy Market 
Fig. 2.     Top-Down Approach   
Fig. 3.     Bottom-Up Approach   
Fig. 4.     Market Highlights Of CAR T Cell Therapy
Fig. 5.     Value Chain Analysis
Fig. 6.     Porter’s Five Forces Analysis
Fig. 7.     Global CAR T Cell Therapy Market By Target Antigen
Fig. 8.     Global CAR T Cell Therapy Market By Therapeutic Application
Fig. 9.     Global CAR T Cell Therapy Market By Geography
Fig. 10.   North America CAR T Cell Therapy Market
Fig. 11.   Europe CAR T Cell Therapy Market
Fig. 12.   Asia Pacific CAR T Cell Therapy Market
Fig. 13.   Latin America CAR T Cell Therapy Market
Fig. 14.   Middle East And Africa CAR T Cell Therapy Market
Fig. 15.   Market Share Of CAR T Cell Therapy Companies
Fig. 16.   Recent Developments In CAR T Cell Therapy Industry
 
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.  

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials